Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
STAR Protocols|July 21, 2020
An Optimized Chromatin Immunoprecipitation Protocol for Quantification of Protein-DNA InteractionsWim J de Jonge, Mariël Brok, Patrick Kemmeren, et al.
Molecular Systems Biology|December 6, 2020
Genome-wide off-rates reveal how DNA binding dynamics shape transcription factor functionWim J de Jonge, Mariël Brok, Philip Lijnzaad, et al.
Molecular Pharmacology|February 21, 2002
Inactivation of the Saccharomyces cerevisiae SKY1 gene induces a specific modification of the yeast anticancer drug sensitivity profile accompanied by a mutator phenotypePaul W Schenk, Antonius W M Boersma, Mariël Brok, et al.
Blood|July 15, 2004
Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pumpHerman Burger, Hans van Tol, Antonius W M Boersma, et al.
Cancer Biology & Therapy|June 23, 2005
Chronic imatinib mesylate exposure leads to reduced intracellular drug accumulation by induction of the ABCG2 (BCRP) and ABCB1 (MDR1) drug transport pumpsHerman Burger, Hans van Tol, Mariël Brok, et al.
Nature Communications|May 27, 2023
Single-cell transcriptomics reveals immune suppression and cell states predictive of patient outcomes in rhabdomyosarcomaJeff DeMartino, Michael T Meister, Lindy L Visser, et al.
Neuro-Oncology|July 29, 2025
A cycling, progenitor-like cell population at the base of atypical teratoid rhabdoid tumor subtype differentiation trajectoriesEnrique Blanco-Carmona, Irene Paassen, Jiayou He, et al.
EMBO Molecular Medicine|August 2, 2022
Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypesMichael T Meister, Marian J A Groot Koerkamp, Terezinha de Souza, et al.
Pageof 1